Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum

Company Overview - Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for serious diseases [2] - The company is currently developing Prademagene zamikeracel (pz-cel), an investigational autologous, COL7A1 gene-corrected epidermal sheet for recessive dystrophic epidermolysis bullosa [2] - Abeona has a fully integrated cell and gene therapy cGMP manufacturing facility that supports the production of pz-cel for its Phase 3 VIITAL™ trial and is capable of commercial production upon FDA approval [2] - The company is also working on AAV-based gene therapies for ophthalmic diseases, utilizing next-generation AAV capsids to enhance tropism profiles for various diseases [2] Upcoming Events - Abeona's CEO, Vish Seshadri, and Chief Commercial Officer, Madhav Vasanthavada, will participate in a virtual fireside chat at the Stifel Virtual Cell Therapy Forum on July 9, 2024, at 9:45 a.m. Eastern Time [1] - A live webcast of the event will be available on the Investors section of the Abeona website and will be archived for 30 days [1]